πŸ‡ΊπŸ‡Έ FDA
Patent

US 8404806

Isolated BRCA1 peptides and method of use

granted A61KA61K38/1709A61K38/1761

Quick answer

US patent 8404806 (Isolated BRCA1 peptides and method of use) held by The Regents of the University of California expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/1709, A61K38/1761, A61P, A61P35/00